Saturday, March 28, 2020 2:01:25 AM
Because a quorum was not represented at the Special Meeting,
shareholders voted to adjourn the meeting in order to allow
additional time for shareholders to vote on the proposal.
Accordingly, the Special Meeting was adjourned to 10:00 a.m., local time, on
Monday, March 30, 2020, at the offices of Ballard Spahr LLP, 1909 K Street, NW,
12th Floor, Washington DC. OpGen’s shareholders as of the record date
of January 24, 2020 will continue to be entitled to vote at the Special Meeting on March 30, 2020.
OpGen and Curetis entered into a definitive agreement
Recent OPGN News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 09/20/2024 05:49:11 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM